Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Stanford University |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00507702 |
To identify unique blood markers in cancer patients so that we can identify patients with evidence of pre-existing immunity who may be a responder to immunotherapy.
Condition |
---|
Cancer |
Study Type: | Observational |
Study Design: | Screening, Cross-Sectional, Defined Population, Prospective Study |
Official Title: | Identification of Key Blood Molecular Markers for Immunotherapy |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Robin M Cisco | 650-723-5570 | rcisco@stanford.edu |
United States, California | |
Stanford University Cancer Center | Recruiting |
Stanford, California, United States, 94305 | |
Contact: Stanford Cancer Clinical Trials Office 650-498-7061 |
Principal Investigator: | Jeffrey Norton, M.D. | Stanford University |
Study ID Numbers: | VAR0017 |
Study First Received: | July 24, 2007 |
Last Updated: | July 25, 2007 |
ClinicalTrials.gov Identifier: | NCT00507702 |
Health Authority: | United States: Institutional Review Board |